In The News
Stat News – Better lab test standards can ensure precision medicine is truly precise
Cancer is becoming less deadly in America. According to the recently released Annual Report to the Nation on the Status of Cancer, overall cancer death rates
PR Newswire – Aetion Leads Cross Industry Initiative to Understand Strengths and Limitations of Regulatory Use of Real-World Evidence
NEW YORK, Nov. 29, 2022 /PRNewswire/ — Aetion, the global leader in real-world evidence (RWE) technology and analytics, today announced the launch of the Coalition for the Advancement
InsideHealthPolicy – Pazdur, Califf Seek To Simplify Trials, Ensure They Represent U.S. Patients
FDA chief Robert Califf and Oncology Center of Excellence head Richard Pazdur are worried about clinical trials being moved outside of the United States, and
Pink Sheet – US FDA Implementing Hybrid Work Policy In January
The US Food and Drug Administration will not require all employees to resume their daily treks to the office going forward, choosing a “hybrid workplace
Politico Pro – FDA unveils hybrid back-to-office policy
SCOOP: FDA SELECTS HYBRID WORK ENVIRONMENT FOR 2023 — Food and Drug Administration leadership has chosen a hybrid work environment for the agency starting in January, a spokesperson confirmed
Pink Sheet – Project Pragmatica: US FDA’s OCE Initiative Aims To Encourage Simple Clinical Trials
Richard Pazdur likely did not surprise anyone when he complained to Friends of Cancer Research Annual Meeting attendees that oncology clinical trials are too complicated.
The Cancer Letter – A “new normal” for NCI-sponsored clinical trials is long overdue
I read with interest the recently published story on the recommendations to streamline data collection in certain NCI trials presented at the Nov. 9, 2022,
BioCentury – FDA, NCI study will serve as prototype for streamlined pragmatic trials
Two U.S. government agencies, two pharmaceutical companies and an academic cooperative trials group are collaborating to conduct a pragmatic clinical trial of a combination therapy
PR Newswire – NIXON NATIONAL CANCER CONFERENCE TO EXAMINE CANCER RESEARCH BREAKTHROUGHS FROM PATIENT PERSPECTIVE
YORBA LINDA, Calif., Nov. 18, 2022 /PRNewswire/ — Inspired by the success of the first Nixon National Cancer Conference in 2021, the Richard Nixon Foundation has announced
Pink Sheet – US FDA’s Pazdur Suggests NCI Should Help Sponsors Enroll Clinical Trials For Innovative Drugs
Oncology sponsors could overcome problems enrolling US patients in clinical trials by enlisting the National Cancer Institute and its network, a US Food and Drug
